Portfolio company
Eli Lilly
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops and sells prescription medicines for patients with conditions including diabetes, obesity, cancer, immunology disorders and neurological diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Lilly
This company manufactures pharmaceutical drugs and digital health tools for patients living with chronic conditions like diabetes, obesity, migraines and autoimmune diseases.
Novo Nordisk
This pharmaceutical company manufactures medicines for patients living with diabetes, obesity and other serious chronic diseases.
Depomed
This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.
Tanabe Pharma
This pharmaceutical company develops and manufactures prescription medicines for patients with central nervous system disorders, autoimmune diseases, diabetes, and kidney conditions.
Carmot Therapeutics
This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.
Regeneron
This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Raziel Therapeutics
This pharmaceutical company develops injectable drugs to treat aesthetic fat conditions and therapeutic fat disorders for patients and healthcare providers.
